Meeting
2019 Genitourinary Cancers Symposium
Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT).
Authors
Lucas W. Dean
University of Alberta, Edmonton, AB, Canada
Lucas W. Dean , Nathan Colin Wong , Shawn Dason , Sumit Isharwal , Mark Donoghue , Liwei Jia , William D. Tap , Gabriella Joseph , Samuel Aaron Funt , Deaglan Joseph McHugh , Hikmat Al-Ahmadie , Victor E. Reuter , Joel Sheinfeld , Dean F. Bajorin , Robert J. Motzer , George J. Bosl , Manjit S. Bains , David Randolph Jones , David B. Solit , Darren R. Feldman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Testicular Cancer
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 531)
DOI
10.1200/JCO.2019.37.7_suppl.531
Abstract #
531
Poster Bd #
M18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Management of relapsed stage I nonseminomatous germ-cell tumor with retroperitoneal only relapse.
First Author: Ahmed Bilal Khalid
Poster
2023 ASCO Genitourinary Cancers Symposium
Relapse-free and overall survival in patients with non-seminomatous testicular germ cell tumours with teratoma-free primaries.
First Author: Pia Paffenholz
Poster
2022 ASCO Annual Meeting
Prognostic significance of raised serum tumor markers (STM) after 2 cycles of chemotherapy in men with intermediate- and poor-risk non-seminomatous testicular germ cell tumors (NSGCT) treated at a single-centre in India.
First Author: ANKUR NANDAN VARSHNEY
Poster
2020 Genitourinary Cancers Symposium
Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT).
First Author: Nabil Adra